期刊簡介預計審稿時間： 約2月

Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science, from a molecular point of view. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Topics of interest include, but are not limited to: cell and tumor biology, angiogenesis, animal models, metastasis, cancer antigens and the immune response to them, cellular signalling and molecular biology, epidemiology, genetic and molecular profiling of cancer and molecular targets, cancer stem cells, DNA damage and repair, cell cycle, apoptosis, molecular virology and vaccine- and antibody-based cancer therapies.

《分子癌癥》從分子角度促進癌癥和相關生物醫學科學領域思想、概念和發現的交流。《分子癌癥》對基礎、轉化和臨床研究的文章感興趣，為理解、預防、診斷和治療癌癥開辟了新途徑。感興趣的主題包括但不限于：細胞和腫瘤生物學、血管生成、動物模型、轉移、癌癥抗原及其免疫反應、細胞信號傳導和分子生物學、流行病學、癌癥和分子靶點的遺傳和分子分析、癌癥干細胞、DNA 損傷和修復、細胞周期、細胞凋亡、分子病毒學以及基于疫苗和抗體的癌癥療法。

《Molecular Cancer》(分子癌)編輯部通訊方式為BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL。如果您需要協助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節省您的寶貴時間，有效提升發表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內容。